Vanderbilt is recruiting individuals who have been diagnosed with Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) to assemble one of the largest data and DNA biobanks of SJS/TEN internationally. This will be used to identify the nature and risk for long-term complications of SJS/TEN and genetic risk factors associated with drug induced SJS/TEN that will translate into improved pre-prescription preventive strategies and care of SJS/TEN.

If you are interested in being a part of our study, please review the study requirements and complete the survey. We anticipate a lot of interest so be sure to allow for ample time for our study team to respond.